Inari Medical, Inc. IPO Advisory
Share this IPO Profile:Smart Search
For IPO Boutique's "scale of 1 to 5" BUY rating on Inari Medical, Inc., and our comprehensive analysis, click "Buy Market Research".
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Inari Medical, Inc. | NARI - NASDAQ |
$14.00-$16.00 | $19.00 | $41.49 | 8.2 million | 5/22/2020 |
| BofA Securities, Morgan Stanley | ||||||
Co-Manager(s): Canaccord Genuity, Wells Fargo Securities | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-02-21 Terms Added 2020-05-18 Terms Changed 2020-05-21 | ||||||
Inari Medical, Inc. Quote & Chart - Click for current quote - NARI
IPO Boutique aggregates information on public companies and private companies, such as "NARI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Inari Medical, Inc. (adapted from Inari Medical, Inc. prospectus):
They are a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "NARI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.